2433:TSEZhongtian Construction (Hunan) Group Limited Analysis
Data as of 2026-05-21 - not real-time
HK$0.08
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical snapshot: The 20‑day SMA (0.0876) sits above both the 50‑day (0.0808) and 200‑day (0.0815) averages, hinting at a modest short‑term upside, yet the MACD histogram is negative and the signal line is bearish, while RSI hovers at 47, suggesting neutral momentum. Volatility is extreme at 86.7% over the past 30 days, and beta is low (0.46), meaning price swings are large but not strongly correlated with the market.
Fundamental backdrop: The stock trades at a deep discount – PB of 0.10 and price‑to‑sales of 0.08 – but earnings are negative (trailing EPS -0.15), margins are in the red (gross 9.9%, operating -24.9%), and ROE is -16.9%. Debt‑to‑equity is high at 22.4, with a max drawdown of 69%, and cash flow generation is essentially zero. No dividend is paid. These mixed signals make the company appear undervalued on price multiples but financially distressed.
Fundamental backdrop: The stock trades at a deep discount – PB of 0.10 and price‑to‑sales of 0.08 – but earnings are negative (trailing EPS -0.15), margins are in the red (gross 9.9%, operating -24.9%), and ROE is -16.9%. Debt‑to‑equity is high at 22.4, with a max drawdown of 69%, and cash flow generation is essentially zero. No dividend is paid. These mixed signals make the company appear undervalued on price multiples but financially distressed.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD signal despite SMA crossover
- High short‑term price volatility
- Neutral RSI indicating no strong momentum
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Deep valuation discount (PB 0.10, P/S 0.08)
- Persistent negative earnings and cash flow
- Potential for restructuring given low market cap
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant undervaluation relative to book and sales
- Low beta suggests limited market‑wide risk exposure
- Opportunity for turnaround if debt is managed and operations improve
Key Metrics & Analysis
Financial Health
Revenue Growth-58.20%
Profit Margin-12.88%
ROE-16.92%
ROA-2.32%
Debt/Equity22.39
P/B Ratio0.1
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI47.4
SupportHK$0.08
ResistanceHK$0.12
MA 20HK$0.09
MA 50HK$0.08
MA 200HK$0.08
MACDBearish
VolumeIncreasing
Fear & Greed Index90.77
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.46
Volatility86.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.